# Heart Failure Precision Medicine Study

Study · id `cardio:ct-nct04196842` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04196842](<https://clinicaltrials.gov/study/NCT04196842>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04196842

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04196842. Randomized; triple masking; primary purpose supportive care. Start 2019-10-16 (actual); primary completion 2026-10-16 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04196842, source copy `cardio:ctgov-nct04196842-2026-02-09`, retrieved 2026-10-26)
- Started: 2019-10-16 (actual) (ClinicalTrials.gov record NCT04196842, source copy `cardio:ctgov-nct04196842-2026-02-09`, retrieved 2026-10-26)
- Primary completion: 2026-10-16 (anticipated) (ClinicalTrials.gov record NCT04196842, source copy `cardio:ctgov-nct04196842-2026-02-09`, retrieved 2026-10-26)
- Completion: 2026-10-16 (anticipated) (ClinicalTrials.gov record NCT04196842, source copy `cardio:ctgov-nct04196842-2026-02-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04196842, source copy `cardio:ctgov-nct04196842-2026-02-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04196842-2026-02-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Heart Failure Precision Medicine Study
- Condition: Heart Failure
- Intervention (Device): Telemonitoring devices
- Lead sponsor: University of California, Davis
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of California, Davis (`cardio:org-university-of-california-davis`)

## Provenance

Content hash: 41002361915f4e95160eee77c29f2871096f3d56c596be8cd4f7db3493761eea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
